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1. Introduction 
Since the discovery [l] that fibrinogen following 
treatment with plasmin (EC 3.4.4.1.4) produces an 
anticoagulant activity and the report that fibrin de- 
position plays a vital role in the growth of some malig- 
nant tumours [2] , considerable interest has been 
shown in the mechanism of proteolysis of fibrinogen 
by plasmin and thrombin (EC 3.4.4.13). During plas- 
min digestion of fibrinogen a large fragment (mole- 
cular weight 160,000), released early in the reaction, 
has been shown to have a maximum anticoagulant 
effect while the high molecular weight end-products 
of digestion exhibit a low but significant inhibition 
of the clotting process [3] . The end or core fragments, 
named D and E, have been physico-chemically and 
immunologically characterized [3-61. The gross 
structure of intact fibrinogen has been described as 
three pairs of polypeptide chains designated (Y (A), 
P (B) and y* [7,8] . The presence of different QI (A), 
/3 (B) and y chains in different populations of fibri- 
nogen molecules from a single donor has been suggest- 
ed recently [9] . Little is known concerning the amino 
acid sequence of the polypeptide chains and their 
location in the molecule. This paper describes the 
subunit molecular weights of human fibrinogen and 
various fragments released during its hydrolysis with 
plasmin. The location of the subunits of the anti- 
coagulant core fragment, D, in native fibrinogen is 
suggested. The spatial positions of the three poly- 
* This nomenclature for the three chains has been recom- 
mended by the International Committee on Hemostasis 
and Thrombosis (Washington, 1967). 
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peptide chains in the intact fibrinogen molecule are 
discussed. 
2. Materials and methods 
Human fibrinogen, KABI, Grade L, Lot no. 459.59 
A.B. KABI, Stockholm, Sweden) prepared from the 
plasma of 4000 donors by the ethanol precipitation 
method of Blomback and BlombIck [lo] was used in 
these experiments.This fibrinogen was pure by acryl- 
amide gel electrophoresis and was over 90% clottable 
by the method of Laki [ 1 I]. Fibrinogen degradation 
products (FDP) were prepared at 25” by the addition 
of 0.14 CTA human plasmin** units per mg of fibri- 
nogen (10 mg/ml in 0.9% NaCl-0.4% sodium citrate, 
pH 7.3 solution). Aliquots were removed at various 
time intervals, the digestion in them stopped with 
0.2 M e-amino-caproic acid (e-ACA) and the samples 
frozen in a methanol-CO2 bath until ready for SDS- 
acrylamide analysis. Overnight (15 hr) digestion 
yielded two plasmin resistant core fragments which 
stained with Amido Black on gel electrophoresis and 
a mixture of low molecular weight, non-staining pep- 
tides [6] . This report deals with molecular weight 
** This plasmin was supplied by Dr. A.J. Johnson, New York 
University Medical Center, School of Medicine, N.Y ., USA. 
The preparation was heterogeneous on acrylamide electro- 
phoresis, was autoactivated in 50% glycerol and contained 
10 CTA units per ml. One CTA (Committee for Thrombo- 
lytic Agents) unit releases 0.1 pmole of tyrosine equivalents 
per minute from Lot CC I -I 6 a-casein (Report of the 
International Committee on Hemostatis and Thrombosis. 
Washington, 1967). 
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Fig. 1. SDS-acrylamide gel patterns of the subunits of human fibrinogen, its plasmin degradation products at various time inter- 
vals and its plasmin resistant ‘core’ fragments, D and E: (a) fibrinogen; fibrinogen digested with plasmin for (b) 2 min (c) 10 min 
(d) 30 min (e) 15 hr; (f) purified ‘core’ fragment D; (g) purified ‘core’ fragment E. The migration distances of the subunits in (f) 
and (g) should not be compared to those in (a-e) since they represent a separate electrophoretic run. Numbers (1,2 etc.) are 
used to identify components other than the polypeptide chains of the intact fibrinogen molecule (o (A) p (B) and y) and the E 
subunits (Es). The nomenclature used is identical to that used in fig. 2. 
measurements and thus the gel electrophoretic 
heterogeneity of D [ 121 is not considered since 
the various D fragments have been shown to have 
about the same molecular weight [ 131 . The core 
fragments, D and E, were isolated from the com- 
plete digest (15 hr) of fibrinogen by DEAE chroma- 
tography [4] and fragment D was further purified 
from traces of core fragment E by Sephadex G-200 
chromatography [ 131. 
The sodium dodecyl sulphate (SDS) gel electro- 
phoretic technique used was a modification of the 
method of Shapiro, Vinuela and Maize1 [ 141 as de- 
scribed by Kerr and Martin [ 151 using 7% polyacryl- 
amide gels. Samples (IO-50 pg per gel) were dissolved 
in 0.01 M phosphate buffer (pH 7.5) 1.0% SDS, 0.1 
M fl-mercaptoethanol and heated at 95” for 10 min. 
Before loading on SDS-acrylamide gels the samples 
were diluted with distilled water to 0.1% SDS. A 
14 
linear relationship was established between the loga- 
rithm of molecular weight and the migration dis- 
tance of known protein markers. The marker pro- 
teins used were pyruvate kinase (molecular weight 
57,000) lactic dehydrogenase (molecular weight 
33,500) chymotrypsinogen (molecular weight 
25,700) and lysozyme (molecular weight 14,300). 
3. Results and discussion 
Fig. 1 shows the SDS-acrylamide gel patterns of 
SDS, fl-mercaptoethanol treated fibrinogen and some 
of its plasmin degradation products released at various 
times during the digestion process. 
Molecular weights of 67,000, 58,000 and 47,000 
were estimated for the (Y (A), P(B) and y polypeptide 
chains respectively in the intact fibrinogen molecule 
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and differ from those reported elsewhere [ 161. The 
2 min digest (fig. lb) shows the absence of intact 
(Y (A) chains with the production of a new fragment 
[4] (molecular weight 3 1,600). The minor compo- 
nents between 4 and the y-chains (fig. 1 b) may be 
intermediate degradation products of CY (A) chains. 
A recent report [ 171 describing the subunit nature 
of thrombin clottable protein in human Bbrinogen- 
plasmin digests suggests that there are two highly 
labile (Y (A) chains in fibrinogen though little infor- 
mation is given concerning the degree of plasminolysis 
or the nature of the plasmin induced fragments of 
the (Y (A) chain complex. The longest surviving in- 
tact chain is +y (fig. Id) which seems to be degraded 
to a new fragment [3] of molecular weight 32,700. 
By inference the 0 (B) chain is the second polypep 
tide chain in the intact fibrinogen molecule to be 
attacked by plasmin and densitometric examination 
of the acrylamide gels shown in fig. lb to d supports 
this inference. In fig. lc the loss of the /3 (B) poly- 
peptide chains coincides with the appearance of com- 
ponent 1 (molecular weight 41,300) which degrades 
to component 2 (molecular weight 37,000) (fig. Id 
and e); at the same time component 4 reduces to a 
final molecular weight of 12,000 (component 6). 
The final core fragments, D and E, of fibrinogen 
digestion with plasmin are of necessity represented in 
their subunit form in fig. 1 e. Other low molecular 
weight peptides are not seen because they are not 
stained with Amido-Black. Fig. 1 f and g depict the 
SDS-acrylamide patterns of the subunits of isolated 
core fragments D and E respectively and their addi- 
tion should yield a subunit pattern as shown in fig. 
le for the complete digest and this is obviously not 
so. The subunits of fragment E stain very poorly and 
required 100 pg to supply the pattern shown in fig. 
Ig and thus would not be shown in the pattern of the 
subunits of the complete digest in fig. le. Fragment 
E after reduction at room temperature comprised a 
single component of molecular weight 44,500 while 
following heating (95” X 10 min) and reduction it 
was converted to a diffuse component (Es) of mole- 
cular weight about 14,500. The pattern in fig. lg 
could be interpreted as three poorly resolved com- 
ponents with a molecular weight range of 12,000- 
18,000, rather than a two component system as has 
been suggested [181, The relatively inaccessible inter- 
chain disulphide bridges of fragment E could explain 
Fig. 2. Proposed sequence of the plasmin degradation of 
polypeptide chains in the intact fibrinogen molecule. (a) 
fibrinogen; fibrinogen digested with plasmin for (b) 2 min 
(c) 10 min (d) 30 min (e) 15 hr; (f) fragment D isolated 
from 15 hr digest of fibrinogen. Molecular weights (X 10e3) 
are in parenthesis to the left of each subunit which is de 
noted by a straight line the length of which is approximate- 
ly proportional to the mole’cular weight. To the right of 
each subunit is an identifying letter or number similar to 
those used in fig. 1. 
the contention [ 191 that the disulphide bridges in 
fibrinogen are mainly intrachain. In comparing fig. 
le and fit would seem that the separation of frag- 
ment E from fragment D results in a reduction in 
the molecular weight of one of its subunits from 
32,700 (component 3) to 24,000 (component 5). 
Indeed it has been found that following the removal 
of core fragment E, the further hydrolysis of sub- 
unit 3 to subunit 5 is accelerated by the addition of 
plasmin or by freezing and thawing. The complete 
disappearance of fragment 3 occurred after further 
digestion. Since molecular weights of 68,000 [20] 
to 83,000 [4] have been reported for unreduced 
fragment D it seems that this fragment in the whole 
digest is made up of three disulphide bonded polypep- 
tide chains (components 2, 3, 6 in fig. le; molecular 
weights 37,600,32,700, and 12,000 respectively) 
having a total molecular weight of 82,300. After 
isolation this fragment also contains three disulphide 
bonded chains (components 2,5,6 in fig. 1 f; mole- 
cular weights 37,600, 24,000 and 12,000 respective- 
ly) and has a molecular weight of 73,600. This sup- 
ports the suggestion [20] that core fragments D and 
E may be linked by non-covalent bonds since frag- 
ment E seemss to inhibit the degradation of one of 
the chains of fragment D. 
These results suggest a sequence of digestion of 
the polypeptide chains in intact fibrinogen as shown 
in fig. 2. The molecular weight estimates for the 
(Y (A), /I (B) and 7 chains (as shown in parenthesis in 
15 
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fig. 2a) suggest a molecular weight for intact fibri- 
nogen of 344,000 assuming a dimeric structure for 
the molecule [7]. Component 4 (fig. 2b) appears 
to be the precursor of the low molecular weight 
fraction (12,000; 6, fig. 2d) and both, together with 
the 12,000 molecular weight subunit of isolated 
fragment D (fig. 2f) appear to arise from (Y (A) chains. 
Similarly it can be argued that the 37,600 and 24,000 
molecular weight fragments of D (fig. 2f) are sec- 
tions of the fl (B) and y chains respectively. These 
stable subfragments of D may prove useful for amino 
acid sequence studies of fibrinogen and for elucidating 
the inherent heterogeneity of the molecule [9] . 
The fact that fibrinogen following limited plasmi- 
nolysis can be clotted with thrombin [21] suggests 
that y chains are vital for the end-to-end polymeri- 
sation step in the coagulation process. The high degree 
of interspecies homology of the N-terminal region 
of the y chain as against that of the (Y (A) and /3 (B) 
chains [22] supports this contention. The suscepti- 
bility of the chains to plasmin attack suggests that 
the lysyi and arginyl residues of the y chains are ini- 
tially inaccessible whereas those of the (Y (A) chains 
and to a lesser extent those of the fl (B) chains, are 
easily hydrolysed which suggests perhaps that the 
(Y (A) chains are located on the outside of the mole- 
cule and the fl (B) and y chains on the inside; how- 
ever, such conclusions require more rigid evidence 
such as might be supplied by X-ray diffraction anal- 
yses in conjunction with sequence analyses. 
Concluding on a practical note, fibrin clot lysis 
methodology [23-251 which is being used to assay 
clinically used thrombolytic agents such as strepto- 
kinase and urokinase should be viewed with caution 
in view of the above described rapid modification of 
the cz (A) chain of fibrinogen in a fibrinolytic environ- 
ment. 
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